Sanofi expands R&D in China with €66m Chengdu Hub
Sanofi will support development of polypeptides, gene therapy, monoclonal antibodies and multi-specific antibodies through the expansion of its R&D plant in Chengdu, Sichuan province, China.
Sanofi will support development of polypeptides, gene therapy, monoclonal antibodies and multi-specific antibodies through the expansion of its R&D plant in Chengdu, Sichuan province, China.
Biogen has announced that it will pay approximately $700m (€600m) to acquire a 49.9% stake in Samsung Bioepis.
Entegris says buying Flex Concepts will help secure its supply of disposable bioprocessing bags and fluid transfer technologies.